| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |